1. Home
  2. HRZN vs VYGR Comparison

HRZN vs VYGR Comparison

Compare HRZN & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRZN
  • VYGR
  • Stock Information
  • Founded
  • HRZN 2008
  • VYGR 2013
  • Country
  • HRZN United States
  • VYGR United States
  • Employees
  • HRZN N/A
  • VYGR N/A
  • Industry
  • HRZN Finance/Investors Services
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HRZN Finance
  • VYGR Health Care
  • Exchange
  • HRZN Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • HRZN 275.7M
  • VYGR 232.4M
  • IPO Year
  • HRZN 2010
  • VYGR 2015
  • Fundamental
  • Price
  • HRZN $6.66
  • VYGR $3.99
  • Analyst Decision
  • HRZN Hold
  • VYGR Strong Buy
  • Analyst Count
  • HRZN 4
  • VYGR 7
  • Target Price
  • HRZN $7.44
  • VYGR $16.17
  • AVG Volume (30 Days)
  • HRZN 630.6K
  • VYGR 468.8K
  • Earning Date
  • HRZN 10-28-2025
  • VYGR 11-10-2025
  • Dividend Yield
  • HRZN 19.82%
  • VYGR N/A
  • EPS Growth
  • HRZN N/A
  • VYGR N/A
  • EPS
  • HRZN N/A
  • VYGR N/A
  • Revenue
  • HRZN $98,899,000.00
  • VYGR $31,316,000.00
  • Revenue This Year
  • HRZN $0.85
  • VYGR N/A
  • Revenue Next Year
  • HRZN $9.80
  • VYGR $107.10
  • P/E Ratio
  • HRZN N/A
  • VYGR N/A
  • Revenue Growth
  • HRZN N/A
  • VYGR N/A
  • 52 Week Low
  • HRZN $5.71
  • VYGR $2.65
  • 52 Week High
  • HRZN $9.99
  • VYGR $7.44
  • Technical
  • Relative Strength Index (RSI)
  • HRZN 56.70
  • VYGR 41.99
  • Support Level
  • HRZN $6.35
  • VYGR $3.81
  • Resistance Level
  • HRZN $6.60
  • VYGR $4.30
  • Average True Range (ATR)
  • HRZN 0.15
  • VYGR 0.26
  • MACD
  • HRZN 0.00
  • VYGR -0.01
  • Stochastic Oscillator
  • HRZN 61.39
  • VYGR 38.14

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: